Related Experiment Video
Updated: Mar 30, 2026

07:13
Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
2.4K
Quantum Dots and their Potential Role in Cancer Theranostics
S K Tripathi1, Gurvir Kaur1, Rajneet Kaur Khurana2
1Centre of Advanced Study in Physics, Department of Physics, Panjab University, Chandigarh-160014, India.
Critical Reviews in Therapeutic Drug Carrier Systems
|November 13, 2015
Summary
Quantum dots (QDs) are advanced nanomaterials enabling precise cancer imaging and drug delivery. This review explores their synthesis, functionalization, and therapeutic applications, highlighting future clinical potential.
Area of Science:
- Nanotechnology
- Bioimaging
- Molecular Biology
- Formulation Development
Background:
- Quantum dots (QDs) are luminescent nanocrystals (NCs) offering a versatile platform for biosystem imaging and targeted therapeutic delivery.
- Their unique optical properties, surface chemistry, and high sensitivity make them ideal for molecular diagnostics and personalized medicine.
Purpose of the Study:
- To review recent advancements in QD synthesis and functionalization for targeted delivery.
- To discuss the application of QDs in anticancer therapy, including drug delivery, gene delivery, and photodynamic therapy (PDT).
- To critically evaluate challenges and future prospects for clinical development of QD-based nanomedicines.
Main Methods:
- Literature review of state-of-the-art advances in QD synthesis and functionalization.
- Analysis of QD applications in drug and gene delivery systems.
- Examination of QD-based photodynamic therapy (PDT) and targeted cancer treatment strategies.
Main Results:
- QDs offer multifunctional capabilities for integrated imaging and therapeutic delivery.
- Functionalization strategies enable targeted delivery of QDs to specific sites.
- QDs show promise in enhancing antitumor therapy through various delivery mechanisms and PDT.
Conclusions:
- QDs represent a highly promising nanoplatform for personalized cancer medicine due to their unique properties.
- Overcoming clinical development impediments is crucial for realizing the full potential of QD-based nanotherapeutics.
- Future advancements in QD synthesis and functionalization will likely drive significant progress in cancer treatment.

